Dianthus Therapeutics, Inc. (XETR:87E) IPO
IPO
Went public as Magenta Therapeutics, Inc. Priced at US$15.00 a share on Jun 20, 2018.
- Price
- US$15.00 a share
- Shares offered
- 6,666,667 shares of common stock
- Offering size
- US$100 million
- Underwriters' option
- Up to 1,000,000 more shares
- Underwriters
- J.P. Morgan, Goldman Sachs & Co. LLC, Cowen, Wedbush PacGrow · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 28, 2018 |
| Filed publicly | May 24, 2018 |
| Amended 3 times | Newest Jun 19, 2018 |
| Shares registered with an exchange | Jun 19, 2018 |
| Declared effective by the SEC | Jun 20, 2018 |
| Final prospectus, with the price | Jun 21, 2018 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 21, 2018 |
| EFFECT · Notice that a registration is effective | Jun 20, 2018 |
| CERT · Exchange's certificate of listing | Jun 20, 2018 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 19, 2018 |
| FWP · Free writing prospectus | Jun 19, 2018 |
| S-1/A · Registration statement, amended | Jun 19, 2018 |
| CORRESP · Letter to the SEC | Jun 18, 2018 |
| CORRESP · Letter to the SEC | Jun 18, 2018 |
| S-1/A · Registration statement, amended | Jun 18, 2018 |
| UPLOAD · Letter from the SEC | Jun 8, 2018 |
| CORRESP · Letter to the SEC | Jun 8, 2018 |
| S-1/A · Registration statement, amended | Jun 8, 2018 |
| CORRESP · Letter to the SEC | May 31, 2018 |
| CORRESP · Letter to the SEC | May 24, 2018 |
| S-1 · Registration statement | May 24, 2018 |
| UPLOAD · Letter from the SEC | May 16, 2018 |
| DRS/A · Draft registration statement, amended | May 8, 2018 |
| DRSLTR · Letter to the SEC with a draft | May 7, 2018 |
| UPLOAD · Letter from the SEC | Apr 24, 2018 |
| DRS · Draft registration statement | Mar 28, 2018 |
From the cover of the final prospectus (424B4) filed Jun 21, 2018